Genelux Common Stock Market Value
| GNLX Stock | 3.40 0.18 5.03% |
| Symbol | Genelux |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genelux Common. If investors know Genelux will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genelux Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Genelux Common is measured differently than its book value, which is the value of Genelux that is recorded on the company's balance sheet. Investors also form their own opinion of Genelux Common's value that differs from its market value or its book value, called intrinsic value, which is Genelux Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genelux Common's market value can be influenced by many factors that don't directly affect Genelux Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genelux Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genelux Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genelux Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Genelux Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genelux Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genelux Common.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Genelux Common on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Genelux Common or generate 0.0% return on investment in Genelux Common over 90 days. Genelux Common is related to or competes with Dyadic International, Cingulate, Monopar Therapeutics, Terns Pharmaceuticals, Day One, Acumen Pharmaceuticals, and Amylyx Pharmaceuticals. More
Genelux Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genelux Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genelux Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.49 | |||
| Information Ratio | 0.1335 | |||
| Maximum Drawdown | 36.53 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 12.6 |
Genelux Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genelux Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genelux Common's standard deviation. In reality, there are many statistical measures that can use Genelux Common historical prices to predict the future Genelux Common's volatility.| Risk Adjusted Performance | 0.1126 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 1.69 | |||
| Sortino Ratio | 0.1689 | |||
| Treynor Ratio | 0.4526 |
Genelux Common Backtested Returns
Genelux Common appears to be relatively risky, given 3 months investment horizon. Genelux Common holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12 % return per unit of risk over the last 3 months. By evaluating Genelux Common's technical indicators, you can evaluate if the expected return of 0.83% is justified by implied risk. Please utilize Genelux Common's Market Risk Adjusted Performance of 0.4626, risk adjusted performance of 0.1126, and Downside Deviation of 5.49 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Genelux Common holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 1.81, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Genelux Common will likely underperform. Please check Genelux Common's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Genelux Common's current trending patterns will revert.
Auto-correlation | -0.41 |
Modest reverse predictability
Genelux Common has modest reverse predictability. Overlapping area represents the amount of predictability between Genelux Common time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genelux Common price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Genelux Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Genelux Common lagged returns against current returns
Autocorrelation, which is Genelux Common stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genelux Common's stock expected returns. We can calculate the autocorrelation of Genelux Common returns to help us make a trade decision. For example, suppose you find that Genelux Common has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Genelux Common regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genelux Common stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genelux Common stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genelux Common stock over time.
Current vs Lagged Prices |
| Timeline |
Genelux Common Lagged Returns
When evaluating Genelux Common's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genelux Common stock have on its future price. Genelux Common autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genelux Common autocorrelation shows the relationship between Genelux Common stock current value and its past values and can show if there is a momentum factor associated with investing in Genelux Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.